Optimizing the use of blood products in trauma care

Critical Care

Volumn 9, Issue SUPPL. 5, 2005, Pages

  Hess, John R ^a   Hiippala, Seppo ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR CONCENTRATE; BLOOD DERIVATIVE; FIBRIN GLUE; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE;

ACIDOSIS; ANAPHYLAXIS; BLEEDING DISORDER; BLOOD BANK; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL STUDY; CLINICAL TRIAL; COST OF ILLNESS; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; MANAGED CARE; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK ASSESSMENT; STRATEGIC PLANNING; UNITED STATES;

ADULT; BLOOD BANKS; BLOOD TRANSFUSION; CRITICAL CARE; HUMANS; PLATELET TRANSFUSION; RESUSCITATION; TRAUMA CENTERS; WOUNDS AND INJURIES;

EID: 31744441332     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc3780     Document Type: Review

References (38)

1. Ozanne-Smith J: Road traffic injury: a global health scourge: a review for World Health Day 2004. Aust NZ J Public Health 2004, 28:109-112.
2. World Health Organization: World Health Report 2003: Shaping the Future. Geneva, Switzerland: World Health Organization; 2003.
3. US Centers for Disease Control and Prevention: Web-based Injury Statistics Query and Reporting System (WISQARS). [http://www.cdc.gov/ncipc/wisqars/]
4. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT: Epidemiology of trauma deaths: a reassessment. J Trauma 1995, 38:185-193.
5. Trunkey DD: History and development of trauma care in the United States. Clin Orthop Relat Res 2000, 347:36-46.
6. Rotondo MF, Zonies DH: The damage control sequence and underlying logic. Surg Clin North Am 1997, 77:761-777.
7. Cosgriff N, Moore EE, Sauaia A, Kenny-Moynihan M, Burch JM, Galloway B: Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidosis revisited. J Trauma 1997, 42:857-861; discussion 861-862.
8. Como JJ, Dutton RP, Scalea TM, Edelman BB, Hess JR: Blood transfusion rates in the care of acute trauma. Transfusion 2004, 44:809-813.
9. Mendelson J: The use of whole blood and blood volume expanders in U.S. military medical facilities in Vietnam. J Trauma 1975, 12:1-13.
10. Moss GS, Valeri CR, Brodine CE: Clinical experience with the use of frozen blood in combat casualties. N Engl J Med 1968, 278:747-752.
11. Gould SA, Sehgal LR, Sehgal HA, Moss GS: The role of hemoglobin solutions in massive transfusion. In Massive Transfusion. Edited by Jefferies LC, Brecher ME. Bethesda, MD: American Association of Blood Banks; 1994:43-64.
12. Camp FR, Conte NF, Brewer JF: Military Blood Banking, 1941-1973. Ft. Know, KY; US Army Medical Research Laboratory; 1973.
13. Thomas MJG: Uncross-matched blood is unnecessary. Hosp Med 2005, 66:96-98.
14. Stainsby D, MacLennan S, Hamilton PJ: Management of massive blood loss: a template guideline. Br J Anaesth 2000, 85:487-491.
15. Dutton RP, Mackenzie CF, Scalea TM: Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 2002, 52:1141-1146.
16. Hirshberg A, Dugas M, Banez El, Scott BG, Wall MJ Jr, Mattox KL: Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 2003, 54:454-463.
17. Spahn DR: Strategies for transfusion therapy. Best Pract Res Clin Anaesthesiol 2004, 18:661-673.
18. Johansson PI, Hansen MB, Sorensen H: Transfusion practice in massively bleeding patients: time for a change? Vox Sang 2005, 89:92-96.
19. Kermode JC, Zheng O, Milner EP: Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood 1991, 94:199-207.
20. Meng ZH, Wolberg AS, Monroe DM III, Hoffman M: The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003, 55:886-891.
21. Levi M, Ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999, 314:586-592.
22. Armand R, Hess JR: Treating coagulopathy in trauma patients. Transfus Med Rev 2003, 17:223-231.
23. Lynn M, Jeroukhimov I, Klein Y, Martinowitz U: Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 2002, 28(Suppl 2):S241-S247.
24. Hess JR, Greenwalt TJ: Storage of red blood cells: new approaches. Transfus Med Rev 2002, 16:283-295.
25. Hiippala S: Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995, 6:743-746.
26. Napolitano LM: Current status of blood component therapy in surgical critical care. Curr Opin Crit Care 2004, 10:311-317.
27. Conry-Cantilena C, Klein HG: Training physicians in the discipline of transfusion medicine: 2004. Transfusion 2004, 44: 1252-1256.
28. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417.
29. Hiippala S: Replacement of massive blood loss. Vox Sang 1998, 74(Suppl 2):399-407.
30. Cushing H: From a Surgeon's Journal. Boston, MA: Little, Brown & Co.; 1936.
31. Kendrick DB: Blood Program in World War II. Washington, DC: Office of the Surgeon General of the Army; 1964.
32. Moore EE: Blood substitutes: the future is now. J Am Coll Surg 2003, 196:1-17.
33. Hess JR: Update on alternative oxygen carriers. Vox Sang 2004, Suppl 2:132-135.
34. Holcomb JB, Pusateri AE, MacPhee MJ, Hess JR: New technologies in hemorrhage control. Curr Opin Crit Care 1997, 3:488-493.
35. Kenet G, Walden R, Eldad A, Martinowitz U: Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999, 354: 1879.
36. Dutton RP, McCunn M, Hyder M, D'Angelo M, O'Connor J, Hess JR, Scalea TM: Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004, 57:709-719.
37. Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y; NovoSeven Trauma Study Group: Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005, 59:8-15.
38. Hess JR, Thomas MJG: Blood use in war and disaster: lessons from the last century. Transfusion 2003, 43:1622-1633.